Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner about NIH website terminology updates and related FAQs was removed from the page.
    Difference
    1%
    Check dated 2026-11-08T08:53:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site revision shown in the footer changes from v3.7.2 to v3.8.0 on the otherwise unchanged 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-01T10:53:21.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH guidance about the transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T11:19:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer now shows revision v3.7.2 instead of v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T10:43:20.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 error page, with its footer revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T11:22:43.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access is blocked; the new markup reflects an error state rather than the typical study information on the page.
    Difference
    20%
    Check dated 2026-09-20T03:55:35.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.